This leading semiconductor company is seeing robust growth thanks to artificial intelligence (AI), and investors can get it for a song.Since early last year, it's become crystal clear that advancements in artificial intelligence (AI) are causing a paradigm shift in technology. Nowhere is that more evident than in the list of companies that are among the world's most valuable, measured in terms of market cap.Microsoft made headlines over the past year or so with its definitive moves in generative AI and is c ...

Are you looking for the hottest artificial intelligence stocks? Here are two red-hot options.Artificial intelligence (AI) stocks are zooming. Even the private market is going like gangbusters. Right now, more than one-fifth of all venture capital funding is going toward AI start-ups, According to a report from Crunchbase.Want to get involved? Here are two AI stocks that have minted a sizable number of new millionaires in recent months.1. Nvidia: This 1 stock is the king of AINo list of red-hot AI stocks wou ...

China's e-commerce and cloud leader is a potential multibagger at these levels.When Alibaba Group (BABA 2.12%) went public at $68 per share on Sept. 18, 2014, it raised $25 billion and became the largest initial public offering (IPO) in U.S. history. At the time, the bulls were impressed by the Chinese e-commerce and cloud leader's rapid growth rates.On Oct. 27, 2020, Alibaba's stock reached its record high of $312.87. That was a near five-bagger gain for its initial investors, and many analysts were convin ...

Core Viewpoint - Novo Nordisk is positioned as a leading healthcare stock with significant growth potential, despite its current high valuation [1] Group 1: Company Performance - Novo Nordisk's market capitalization is around $600 billion, with a remarkable 450% increase in share prices over the past five years [1] - The company reported a 22% increase in sales to 65.3 billion Danish krone ($9.8 billion) and a 28% rise in profits to 25.4 billion Danish krone ($3.8 billion) in the first quarter of the year [5] - Novo Nordisk has consistently generated profit margins exceeding 20%, with current margins at 38 cents of every dollar of revenue [6] Group 2: Product Pipeline and Growth Opportunities - Novo Nordisk's focus on obesity and diabetes treatments positions it well, as these conditions often lead to additional health issues [2] - The glucagon-like peptide 1 (GLP-1) drugs, such as Wegovy and Ozempic, have shown effectiveness beyond their initial indications, including cardiovascular risk reduction and potential kidney disease benefits [3][4] - The FDA's approval of Wegovy for reducing serious heart problems has increased its coverage potential among Medicare beneficiaries [3] Group 3: Investment Potential - If Novo Nordisk maintains strong revenue growth and high profit margins, it could outperform the S&P 500's long-term average return of 10%, potentially averaging returns of 12% to 13% [7] - An investment of over $47,000 today could grow to more than 21 times its original value in 25 years, while a 30-year investment could yield nearly 40 times the initial amount, reaching $1 million with an investment of approximately $25,600 [8] - Despite its high market cap, Novo Nordisk remains a compelling investment opportunity for long-term returns [8]

Altria has a huge yield and a struggling business. I'd rather own this other consumer staples company despite the troubles it's facing.I like to buy companies with long histories of dividend increases while they are offering historically high dividend yields. On the surface, that would suggest that I might want to buy Altria (MO 0.28%) and its huge 8.7% yield. No, thanks: I'd rather own Hormel Foods (HRL 0.61%) and its much lower 3.1% yield. Here's why.Altria's core business is shrinking fastAltria's bigges ...

The farm equipment giant's weaker results reflect challenging macroeconomic conditions for the agriculture industry.Deere & Company (DE 0.66%), a leading manufacturer of agricultural, construction, and forestry machinery, released its fiscal 2024 second-quarter financial results on May 16. For the period, which ended April 28, net income fell 17% year over year to $2.4 billion, while revenue dropped 12% to $15.2 billion. Despite these challenges, the company reiterated its commitment to its strategic initia ...

It's very easy to be bullish when looking at this dominant enterprise and its long-term prospects.While it might sound like a smart idea to try and find small businesses that could become tomorrow's big winners in the stock market, investors can't ignore the companies that are hiding in plain sight.Just look at Alphabet (GOOGL 1.08%) (GOOG 1.06%). The tech titan's shares have soared 190% just in the past five years, far outpacing the broader Nasdaq Composite Index. But I don't think it's done rewarding shar ...

Core Viewpoint - Cracker Barrel Old Country Store is significantly reducing its dividend by 80% to allocate funds for business improvements, leading to a sharp decline in its stock price [1][3]. Financial Performance - The company reported trailing-12-month revenue of $3.4 billion, nearing an all-time high, with comparable-restaurant sales showing modest growth in Q2 of fiscal 2024 [2]. - Despite the revenue figures, earnings per share (EPS) are currently lower than they were a decade ago, indicating underlying financial issues [2]. Dividend Policy Changes - Cracker Barrel has a history of paying quarterly dividends and special dividends, but recent earnings deterioration has led to a situation where dividend payouts exceeded earnings, prompting the drastic cut [3]. - The decision to reduce the dividend is aimed at reallocating resources to fix the business, which has not been well received by investors, resulting in a significant drop in share price [3][4]. Future Outlook - Management is optimistic about turning the business around, with capital expenditures expected to increase through fiscal 2027, aiming for approximately $400 million in adjusted EBITDA by that time [5]. - Currently, the company has an enterprise value (EV) of $1.7 billion, and if it meets its targets, it would trade at an EBITDA-to-EV ratio of four, suggesting potential upside for the stock [6].

The industrial company's stock received another update from a highly regarded analyst recently.Another day, another Wall Street analyst upgrade for 3M (MMM 0.66%) stock. This time, it's from Vertical Research analyst Jeffrey Sprague, who upgraded the stock from "hold" to "buy" and increased his price target from $92 to $140. That target implies a 33% upside over the next 12 months from the current price.Vertical Research may not be a household name among retail investors. Still, I think Sprague is one of th ...

Reddit is partnering up with OpenAI.In today's video, I discuss recent updates impacting Nvidia (NVDA -0.18%) and Reddit (RDDT 13.67%). Check out the short video to learn more, consider subscribing, and click the special offer link below.*Stock prices used were the after-market prices of May 16, 2024. The video was published on May 16, 2024. ...